Publicaciones en colaboración con investigadores/as de University of Florida (37)

2024

  1. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

  2. International Consensus Recommendations for Safe Use of LAMS for On- and Off-Label Indications Using a Modified Delphi Process

    American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 671-681

  3. Pathology-based brain arterial disease phenotypes and their radiographic correlates

    Journal of Stroke and Cerebrovascular Diseases, Vol. 33, Núm. 6

  4. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

2023

  1. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022

    European Journal of Anaesthesiology, Vol. 40, Núm. 4, pp. 226-304

  2. The aorta in humans and African great apes, and cardiac output and metabolic levels in human evolution

    Scientific reports, Vol. 13, Núm. 1, pp. 6841

2022

  1. Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study

    Journal of Clinical Anesthesia, Vol. 80

  2. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

    Hepatology, Vol. 76, Núm. 4, pp. 1121-1134

  3. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  4. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  5. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

    The Lancet. Haematology, Vol. 9, Núm. 5, pp. e374-e384

  6. Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority

    JAMA Neurology, Vol. 79, Núm. 9, pp. 929-936

  7. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 7, pp. 757-767

  3. SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

    Stroke, Vol. 52, Núm. 5, pp. E117-E130

2020

  1. Scaling of Anatomically Derived Maximal Bite Force in Primates

    Anatomical Record, Vol. 303, Núm. 7, pp. 2026-2035

2018

  1. A community approach to mortality prediction in sepsis via gene expression analysis

    Nature Communications, Vol. 9, Núm. 1

  2. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

    The Lancet Haematology, Vol. 5, Núm. 11, pp. e563-e598

  3. Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism

    Journal of Nutritional Biochemistry, Vol. 54, pp. 77-86